These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 33506643)
21. The Value of the CHADS Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449 [TBL] [Abstract][Full Text] [Related]
22. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study). Azarbal F; Welles CC; Wong JM; Whooley MA; Schiller NB; Turakhia MP Am J Cardiol; 2014 Apr; 113(7):1166-72. PubMed ID: 24507169 [TBL] [Abstract][Full Text] [Related]
23. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452 [TBL] [Abstract][Full Text] [Related]
24. Comparison of CHA Hu WS; Lin CL Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919 [TBL] [Abstract][Full Text] [Related]
26. CHADS Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462 [TBL] [Abstract][Full Text] [Related]
27. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score. Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725 [TBL] [Abstract][Full Text] [Related]
28. Which risk score best predicts perioperative outcomes in nonvalvular atrial fibrillation patients undergoing noncardiac surgery? van Diepen S; Youngson E; Ezekowitz JA; McAlister FA Am Heart J; 2014 Jul; 168(1):60-7.e5. PubMed ID: 24952861 [TBL] [Abstract][Full Text] [Related]
30. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604 [TBL] [Abstract][Full Text] [Related]
31. Stroke Risk Scores as Predictors of Severe Outcomes in Atrial Fibrillation: A Comprehensive Review. Ivănescu AC; Buzea CA; Delcea C; Dan GA Am J Ther; 2021 Apr; 28(3):e319-e334. PubMed ID: 33852487 [TBL] [Abstract][Full Text] [Related]
32. Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction. O'Neal WT; Sandesara P; Patel N; Venkatesh S; Samman-Tahhan A; Hammadah M; Kelli HM; Soliman EZ Eur Heart J Cardiovasc Imaging; 2017 Jul; 18(7):725-729. PubMed ID: 28379310 [TBL] [Abstract][Full Text] [Related]
33. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219 [TBL] [Abstract][Full Text] [Related]
34. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database. van den Ham HA; Klungel OH; Singer DE; Leufkens HG; van Staa TP J Am Coll Cardiol; 2015 Oct; 66(17):1851-9. PubMed ID: 26493655 [TBL] [Abstract][Full Text] [Related]
35. CHADS2, CHA2DS2-VASc, and R2CHADS2 scores are associated with 3-month functional outcome of stroke in patients with prior coronary artery disease. Hoshino T; Ishizuka K; Shimizu S; Uchiyama S Circ J; 2014; 78(6):1481-5. PubMed ID: 24694770 [TBL] [Abstract][Full Text] [Related]
36. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143 [TBL] [Abstract][Full Text] [Related]
37. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082 [TBL] [Abstract][Full Text] [Related]
38. Competitive interaction between chronic obstructive pulmonary disease and CHA Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184 [TBL] [Abstract][Full Text] [Related]
39. CHADS Huang FY; Huang BT; Pu XB; Yang Y; Chen SJ; Xia TL; Gui YY; Peng Y; Liu RS; Ou Y; Chen F; Zhu Y; Chen M Intern Emerg Med; 2017 Jun; 12(4):479-486. PubMed ID: 28161883 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Apostolakis S; Lane DA; Buller H; Lip GY Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]